(Washington, DC)—The Pharmaceutical Care Management Association (PCMA) released the following statement today supporting legislation introduced by Chairman Frank Pallone (D-NJ) of the House Energy and Commerce Subcommittee on Health:

“PCMA applauds the legislation introduced by Chairman Pallone earlier this week that would fix the flawed Average Manufacturer Price (AMP) final rule, mandated under the Deficit Reduction Act.

“PCMA supports the decision to remove PBM retail business rebates and discounts from inclusion in the final AMP rule. However, we remain concerned that mail-service and specialty pharmacy are still included in the definition of AMP. This definition is an inaccurate reflection of the retail class of trade price. Fixing AMP is important so that pharmacists can receive adequate reimbursements in Medicaid, ensuring consumers continued access to their community pharmacies.”

###

PCMA is the national association representing America’s pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D.

Contact Information:
Charles Coté 202-207-3605